Meeting
2017 ASCO Quality Care Symposium
Impact of genomic profiling on treatment decisions for patients with melanoma and colorectal cancer cohorts.
Authors
Eman Biltaji
Program in Personalized Healthcare, University of Utah, Salt Lake City, UT
Eman Biltaji, Trang H. Au, Keith Gligorich, Mary P. Bronner, David D. Stenehjem, Diana I. Brixner
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cost, Value, and Policy in Quality; Practice of Quality
Track
Cost, Value, and Policy in Quality,Practice of Quality
Sub Track
Learning from Projects Done in a Practice
Citation
J Clin Oncol 35, 2017 (suppl 8S; abstract 66)
DOI
10.1200/JCO.2017.35.8_suppl.66
Abstract #
66
Poster Bd #
C7
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
Impact of next-generation sequencing (NGS) on treatment decisions in the community oncology setting.
First Author: Lindsay Carol Overton
Poster
2024 ASCO Annual Meeting
Comparative analysis of actionable gene reporting in targeted panels versus comprehensive NGS testing for solid tumor samples.
First Author: Chaugiang Duong
Poster
2024 ASCO Annual Meeting
Characterization of diverse targetable ERBB2 alterations in 512,993 patients with solid tumors.
First Author: Dazhi Liu
Poster
2023 ASCO Annual Meeting
Liquid-biopsy detection of FGFR2 and other actionable rearrangements in GI malignancies.
First Author: Pashtoon Murtaza Kasi